Pharmacokinetics and Excretion of Oral [14C]-Rodatristat Ethyl

Summary

This is an open-label study to evaluate the PK and excretion of a single oral dose of \[14C\]-rodatristat ethyl. The study will consist of: Screening evaluations (within 29 days prior to dosing); a treatment phase (from dosing until discharge from the unit, a minimum of 7 days and a maximum of 14 days); and discharge procedures.

Timeline

Start

2021-09-23

Primary completion

2021-10-06

Completion

2021-10-06

Drugs

Indications

No indication recorded.